Purchase Order HHSN272201200077P
- Not listed
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products, to expand a high-fidelity PCR system for a large experiment requiring PCR amplification. The contract, with a ceiling value of $7,796.00, has a completion date of July 13, 2011. Roche Diagnostics is a global leader in diagnostic solutions, providing a wide...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The award, valued at $10,914.40, is for the expansion of a high fidelity polymerase chain reaction (PCR) system and the procurement of seven high fidelity PCR kits for genomic testing. The contract was awarded on July 27, 2011, with an ultimate completion date of August 5, 2011. The...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), awarded a $3,118.40 firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostic products. The contract is for PCR kits, with an ultimate completion date of October 17, 2012. Roche Diagnostics has held various federal contracts and subcontracts to provide medical equipment, reagents, and...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the Department of Health and Human Services, to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $4,380.08 contract is for the provision of detection kits and supplies to be used with the Discovery Ultra Stainer. The contract has no set-aside designation. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract, valued at $5,363.55, is for the procurement of ROCHE 454 INSTRUMENT CHEMICALS AND CONSUMABLES. This award is not designated as a set-aside contract. Roche Diagnostics holds multiple significant Indefinite Delivery Contracts...
- This is a $3,118.40 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Roche Diagnostics Corporation. The contract is not set aside for any specific business type. Roche Diagnostics, a manufacturer of in vitro diagnostics and associated products and services, is providing critical care analyzers, reagents, test kits, and related laboratory equipment, supplies, and services to...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the procurement of DNA polymerase for experiments, with a ceiling value of $3,283.84 and a completion date of June 19, 2011. The contract was not set aside for any specific business type. Roche Diagnostics Corporation...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Roche Diagnostics Corporation to expand a high-fidelity polymerase chain reaction (PCR) system for genomic testing. The $3,118.40 contract has an ultimate completion date of January 23, 2012 and did not utilize a small business set-aside. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics,...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $3,452.60 contract is for the delivery of unspecified products or services. The award is not designated as a set-aside. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
- This is a firm fixed-price purchase order awarded by the U.S. Department of Agriculture's (USDA) Agricultural Research Service to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract is for $6,333.81 and provides sequencing reagents and consumables for a GS 454 FLX+ Titanium DNA Sequencer. The contract has no set-aside designation, indicating Roche Diagnostics competed openly for this award. Roche Diagnostics is a...
This is a $3,118.40 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostic products. The contract is for the expansion of high fidelity enzyme blends for the amplification of genomic DNA targets. The contract has no set-aside designation, indicating it was competed openly. Roche Diagnostics is a global leader in diagnostic solutions and has secured multiple Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with federal agencies such as the Department of Veterans Affairs and Defense Health Agency for a range of medical diagnostic technologies, including equipment, reagents, and testing services. The company's federal contract awards cover a broad spectrum of applications, from COVID-19 testing to chronic disease management, supporting the medical research, disease detection, and patient care missions of various civilian and defense healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Funding Only Action | ($50) | 11/29/11 | |
| Not listed | Not listed | $3.2k | 11/16/11 |